Gene-Edited Pig Kidneys Could Help Patients Waiting for Human Organ Donors

The global shortage of donor organs has encouraged scientists to explore an increasingly ambitious solution: using genetically modified pig organs to help people survive while they wait for a human transplant.

Recent research involving a 66-year-old US patient has added new momentum to the field of xenotransplantation, the medical practice of transplanting organs from one species into another. The patient lived without dialysis for nine months after receiving a genetically engineered pig kidney before eventually undergoing a human kidney transplant.

The case could represent an important step toward using pig kidney transplants as a temporary bridge for patients with kidney failure.

Why Are Scientists Studying Pig Organ Transplants?

Kidney disease affects millions of people worldwide, while the supply of suitable donor organs remains limited. For patients with advanced kidney failure, dialysis can keep them alive, but it can be physically demanding and does not provide all the benefits of a functioning kidney transplant.

A successful human kidney transplant can significantly improve quality of life. The problem is that many patients wait months or years for a suitable donor.

This shortage has led researchers to investigate whether animal organs could provide an alternative source of transplantation.

Pigs are particularly attractive candidates because their organs are broadly comparable to human organs in size and anatomy. However, simply transplanting an ordinary pig kidney into a human would trigger powerful immune reactions.

Genetic engineering is therefore being used to alter pig organs before transplantation.

How Genetic Engineering Could Make Pig Organs Compatible

One of the biggest challenges in xenotransplantation is rejection. The human immune system is designed to identify foreign biological material and attack it.

Scientists can modify specific genes in pigs to reduce the likelihood that their organs will be immediately rejected by the human body. Modern technologies, including CRISPR-based gene editing, have made it possible to make targeted changes to animal DNA.

These modifications can potentially remove or alter biological features that cause the human immune system to attack the transplanted organ.

Researchers are also studying ways to manage other risks associated with animal-to-human transplantation, including infections and longer-term immune responses.

The objective is not simply to make a pig kidney function temporarily. Scientists ultimately want to determine whether such organs could provide reliable, safe and lasting treatment.

A Nine-Month Milestone for Pig Kidney Transplants

One of the most notable recent cases involved Tim Andrews, a patient from New Hampshire who had end-stage kidney disease.

In January 2025, doctors transplanted a genetically modified pig kidney into Andrews. According to researchers, the kidney began functioning after transplantation and allowed him to remain free from dialysis for 271 days.

The organ was eventually removed after developing significant blood-vessel damage and declining function. Andrews subsequently received a kidney from a human donor.

Although the pig kidney did not provide a permanent solution, researchers believe the case demonstrates how xenotransplantation might eventually serve as a temporary treatment.

For someone facing a prolonged wait for a human organ, even several months without dialysis could potentially make a major difference.

What Does This Mean for Patients on Transplant Waiting Lists?

The concept of a "bridge" transplant is particularly important.

Instead of replacing human kidney donation, a genetically modified pig kidney could potentially keep a patient healthier while they wait for a compatible human organ.

That could be especially valuable for people whose medical condition makes long-term dialysis difficult or who face an extended period on a transplant waiting list.

However, researchers stress that the technology remains experimental.

A successful individual case does not establish that pig kidneys are ready for widespread clinical use. Larger studies are needed to determine how consistently the organs function, how long they can survive in human recipients and what complications may emerge over time.

Previous Pig Kidney Transplants Have Had Mixed Results

The latest case follows earlier attempts to transplant genetically modified pig kidneys into living humans.

In 2024, a patient at Massachusetts General Hospital received a pig kidney transplant and survived for several weeks. The patient later died from cardiovascular complications that doctors said were not caused by the transplanted kidney.

Other experimental procedures involving animal organs are also being explored. Researchers have investigated pig hearts, lungs and other organs as potential future sources of transplantation.

These experiments are part of a much broader effort to determine whether xenotransplantation can eventually address the shortage of human donor organs.

Safety Remains a Major Question

Despite the promising results, safety remains one of the most important issues.

Animal-to-human transplantation creates concerns about immune rejection, organ failure and the possible transmission of infectious agents from animals to humans.

Researchers monitoring the recent pig kidney case reported that they did not detect pig viruses or other pig-related pathogens in the patient.

That is encouraging, but continued monitoring is essential. Some risks could potentially become apparent only after larger numbers of patients have received animal organs or after recipients have been monitored for longer periods.

Regulators and medical institutions will therefore need to evaluate evidence carefully before xenotransplantation becomes routine.

Ethical Questions Surround Pig Organ Transplants

The science also raises ethical questions surrounding animal welfare and the genetic modification of pigs.

If genetically engineered animals become a major source of organs for human transplantation, governments and medical organisations will need clear standards covering how the animals are bred, housed and used.

There are also questions about informed consent. Patients participating in early-stage xenotransplantation research are accepting risks that may not yet be fully understood.

For this reason, the people who volunteer for experimental procedures play an important role in advancing medical research.

Could Pig Kidneys Become a Routine Treatment?

It is too early to know whether pig kidneys will eventually become a standard part of transplant medicine.

The recent case provides evidence that a genetically modified pig kidney can perform kidney functions in a human for a substantial period. But researchers still need to establish whether the approach can be made consistently safe and effective.

If future studies produce positive results, xenotransplantation could potentially develop in several directions.

Initially, pig kidneys may be used as temporary support for patients waiting for human donors. In the longer term, researchers hope animal organs could become permanent transplant options for some patients.

Such a development could fundamentally change the organ donation system by creating a new source of transplantable organs.

Human Organ Donation Is Still Essential

Even as scientists investigate xenotransplantation, conventional organ donation remains critically important.

Human donor kidneys have a long-established role in transplant medicine, and genetically engineered animal organs are not currently a replacement for them.

The development of pig organ transplantation should therefore be viewed as an additional potential solution to the organ shortage rather than an immediate substitute for human donation.

For now, researchers are continuing to investigate whether genetically modified pig organs can safely provide the extra supply that transplant medicine desperately needs.

The story of patients such as Andrews highlights both the potential and the uncertainty of this emerging technology. If further research confirms its safety and durability, pig organs could eventually help bridge one of medicine's most persistent challenges: finding enough organs for people who urgently need them.

Source

The Lancet by researchers associated with Mass General Brigham and related US medical institutions.

Disclaimer

This article is for general informational purposes only and is not medical advice. Xenotransplantation remains an experimental area of medicine, and its risks, benefits and availability may change as research develops. Patients should speak with qualified healthcare professionals about their individual treatment options.